The tricyclic antidepressant clomipramine increases plasma glucose levels of mice

Journal of Pharmacological Sciences

Volumn 93, Issue 1, 2003, Pages 74-79

  Sugimoto, Yumi ^a   Inoue, Kiyo ^a   Yamada, Jun ^a  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

5 HT2B 2C receptor; 5 Hydroxytryptamine (5 HT); Antidepressant; Clomipramine; Hyperglycemia

Indexed keywords

1 ISOPROPYL 6 METHYLERGOLINE 8 CARBOXYLIC ACID 2 HYDROXY 1 METHYLPROPYL ESTER; 1,2,3,5 TETRAHYDRO 5 METHYL 1 (3 PYRIDYLCARBAMOYL)PYRROLO[2,3 F]INDOLE; ADRENALIN; CLOMIPRAMINE; FENCLONINE; GLUCOSE; KETANSERIN; METHYSERGIDE; PROPRANOLOL; SEROTONIN; SEROTONIN 1 ANTAGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1B ANTAGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2B ANTAGONIST; SEROTONIN 2B RECEPTOR; SEROTONIN 2C ANTAGONIST; SEROTONIN 2C RECEPTOR; SEROTONIN 5 ANTAGONIST; SEROTONIN 7 ANTAGONIST; SEROTONIN ANTAGONIST; TRICYCLIC ANTIDEPRESSANT AGENT; TROPISETRON; UNCLASSIFIED DRUG;

ADRENALECTOMY; ADRENALIN RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG INDUCED DISEASE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; MALE; MOUSE; NONHUMAN; RECEPTOR BLOCKING;

ADRENALECTOMY; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BLOOD GLUCOSE; CLOMIPRAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERGLYCEMIA; MALE; MICE; SEROTONIN AGENTS;

EID: 0141955259     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.93.74     Document Type: Article

References (18)

1. Briley M, Moret C. Neurobiological mechanisms involved in antidepressant therapies. J Clin Neuropharmacol. 1993;16:24-35.
2. McTavish D, Benfield P. Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder. Drugs. 1990;39:136-153.
3. Lopez-Ibor JJ Jr, Saiz J, Cottraux J, et al. Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder. Eur Neuropsychopharmacol. 1996;6:111-118.
4. Rouillon F. A double-blind comparison of fluvoxamine and clomipramine in OCD. Eur Neuropsychopharmacol. 1998;8:S260-S261.
5. Porsolt RD, Bertin A, Jalfre M. Behavioural despair in mice: A primary screening test for antidepressants. Arch Int Pharmacodyn. 1977;229:327-336.
6. 2 receptor antagonist on the anti-immobility effects noradrenaline and serotonin reuptake inhibitors in the forced swimming test. Brain Res. 2002;958:161-168.
7. Njung'e K, Handley SL. Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice: A putative test for anxiolytic agents. Br J Pharmacol. 1991;104:105-112.
8. Hyttel J. Pharmacological characterization of the selective serotonin reuptake inhibitors (SSRI's). Int J Pharmacol. 1994;9:19-26.
9. 1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat. J Pharmacol Exp Ther. 1987;243:1159-1166.
10. 2 receptors are involved in the adrenal catecholamine-releasing and hyperglycemic effects of the 5-hydroxytryptamine indirect agonist d-fenfluramine in the conscious rat. J Pharm Exp Ther. 1992;260:1008-1016.
11. 2C/2B receptor agonist 1-(3-chlorophenyl)piperazine on the plasma glucose levels of rats. Eur J Pharmacol. 1996;307:75-80.
12. 1A receptor agonist buspirone on the blood glucose and pancreatic hormones in rats. Jpn J Pharmacol. 1992;60:145-148.
13. Sugimoto Y, Inoue K, Yamada J. Involvement of serotonin in zimelidine-induced hyperglycemia in mice. Biol Pharm Bull. 1999;22:1240-1241.
14. Yamada J, Sugimoto Y, Inoue K. Selective serotonin reuptake inhibitors fluoxetine and fluvoxamine induce hyperglycemia by different mechanisms. Eur J Pharmacol. 1999;382:211-215.
15. Gupta B, Awasthi A, Jaju BP. Effect of acute & chronic imipramine treatment on glucose homeostasis. Indian J Med Res. 1992;96:65-71.
16. 2C receptor. Psychopharmacology (Berl). 1996;126:234-240.
17. 2 receptor subtypes: A family re-united? Trends Pharmacol Sci. 1995;16:105-110.
18. 2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex, in vivo. Neuropharmacology. 1998;37:953-955.